一、文章
1.Zhao G, Zhou Z. Correlation between obesity-related indices and hypertension. Am J Transl Res. 2024 Aug 15;16(8):3842-3850. doi: 10.62347/UUFG4260. PMID: 39262745; PMCID: PMC11384390.（F=1.7）
2. Chen Cheng#, Weixi Jiang#, Yuanli Luo#, Li Wan, Xun Guo, Zhuoyan Xie, Rui Tang, Tong Huang, Jingxue Wang, Chier Du, Zhigang Wang, Haitao Ran, Pan Li,Zhiyi Zhou*, Jianli Ren*. NIR activated multimodal therapeutics based on metal-phenolic networks-functionalized nanoplatform for combating against multidrug resistance and metastasis.Small, 2023 Apr;19(14): e2206174. (IF=15.153)
DOI：1002/smll.202206174.
3.Zhuoyan Xie#,Junrui Wang#,Yuanli Luo,Bin Qiao,Weixi Jiang,Leilei Zhu,Haitao Ran,Zhigang Wang,Wei Zhu*,Jianli Ren*,Zhiyi Zhou*. Tumor-penetrating nanoplatform with ultrasound “unlocking” for cascade synergistic therapy and visual feedback under hypoxia.Journal ofnanobiotechnology, 2023 Jan 25;21(1):30. (IF=10.2)
DOI:10.1186/s12951-023-01765-x
4.Yuanli Luo＃, Bin Qiao＃, Chao Yang＃, Ping Zhang, Zhuoyan Xie, Jin Cao, Anyu Yang, Qinyanqiu Xiang, Haitao Ran, Zhigang Wang, Lan Hao, Yang Cao,Zhiyi Zhou*, Jianli Ren*. Low intensity focused ultrasound ignited “deep-penetration nanobomb” (DPNB) for tetramodal imaging guided hypoxia-tolerant sonodynamic therapy against hypoxic tumors. International journal of nanomedicine, 2022 Sep 27;17:4547-4565.(IF=7.033) 共同通讯作者
DOI：10.2147/IJN.S361648.
5. Weixi Jiang, Lei Su, Meng Ao, Xun Guo, Chen Cheng, Yuanli Luo, Zhuoyan Xie, Xingyue Wang, Junrui Wang, Shuling Liu, Yang Cao, Pan Li, Zhigang Wan, Haitao Ran,Zhiyi Zhou*, Jianli Ren*.Amplifed antitumor efficacy by a targeted drug retention and chemosensitization strategy-based “combo” nanoagent together with PD-L1 blockade in reversing multidrug resistance.Journal ofnanobiotechnology, 2021,19(1):200-222.(IF=10.43)，共同通讯作者2021 Jul 5
DOI: 10.1186/s12951-021-00947-9. 1477-3155
6.Yuanli Luo＃,Bin Qiao＃,Ping Zhang,Chao Yang,Jin Cao,Xun Yuan,Haitao Ran,Zhigang Wang,Lan Hao,YangCao,Jianli Ren*,Zhiyi Zhou*.TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy. Theranostics,2020,10(15):6987-7001.(IF=8.579) 共同通讯作者 2020 May 25
DOI:10.7150/thno.44569
7.Hongyun Zhao＃,Meng Wu＃,Leilei Zhu,Yi Tian,Mingxing Wu,Yizhen Li,Liming Deng,Wei Jiang,Wei Shen,Zhigang Wang,Zhechuan Mei,Pan Li,Haitao Ran,Zhiyi Zhou*,Jianli Ren*. Cell-penetratingpeptide-modified targeted drug-loaded phase-transformation lipid nanoparticles combined with low-intensity focused ultrasound for precision theranostics against hepatocellular carcinoma. Theranostics, 2018,8(7):1892-1910. (IF=8.766) 2018 Feb 14
DOI:http://dx.doi.org/10.7150/thno.22386
8.Jianli Ren,Ping Zhang,Ju Tian,Zhiyi Zhou*,Xingzhao Liu,Dong Wang*,Zhigang Wang. A targeted ultrasound contrast agent carrying gene and cell-penetrating peptide: preparation and gene transfection in vitro.Colloids and surfaces. B, Biointerfaces.2014,121:362-370. (IF=4.287) 2014 Sep 1
DOI:http://dx.doi.org/10.1016/j.colsurfb.2014.06.017
9.Zhiyi Zhou,Ping Zhang,Jianli Ren*,Haitao Ran,Yuanyi Zheng,Pan Li,Qunxia Zhang,Maohui Zhang,Zhigang Wang*. Synergistic effects of ultrasound-targeted microbubble destruction and TAT peptide on gene transfection: an experimental study in vitro and in vivo. Journal of controlled release, 2013,170 (3): 437-444. (IF=7.633)
二、专利
HA介导CPPs修饰的载10-HCPT相变脂质纳米粒及其制备方法
专利号：ZL 2018 1 0129704.7
授权公告号：CN 108283721 B
发明人：周志益等
三、项目
1.国家自然科学基金面上项目，82472006，多模态成像监测下SDT协同“PS翻转纳米开关”用于改善肿瘤免疫化疗耐受的研究，2025/01-2028/12，项目负责人
2.重庆市自然科学基金面上项目，CSTB2024NSCQ-MSX0419，肽介导型多功能纳米阵调控脂肪褐变用于肥胖症治疗及疗效监控研究，2025/01-2027/12，项目负责人
3.重庆市科卫联合医学科研重点项目，2025ZDXM033，肥胖人群“BMA12条”生活化减重与心功能、生物学年龄关系的临床研究，2025/01-2027/12，项目负责人
4.重庆市渝中区基础研究与前沿探索项目，20190112，肽功能化载GOx靶向相变超声分子探针用，2020/01-2022/12，项目负责人
5.国家自然科学基金面上项目，61471074，声控CPPs介导叶酸靶向载10-HCPT相变，2015/01-2018/12，项目负责人
6.重庆市科委基础与前沿研究计划项目，cstc2014jcyjA10096，CPPs介导靶向载药相变纳米粒研制及应用研究，2014/03/06-2017/09/01，项目负责人
7.重庆市医学科研计划面上项目，2013-2-94，动脉血栓性疾病新型诊疗策略研究，2013/03/24-2017/04/12，项目负责人
